Status:
NOT_YET_RECRUITING
Virtual Evaluations of Joint Health Using Wearable Sensors in Persons With Haemophilia (VESPA)
Lead Sponsor:
East Kent Hospitals University NHS Foundation Trust
Conditions:
Haemophilia
Eligibility:
All Genders
13+ years
Brief Summary
Recent technological innovations have enabled the creation of portable and easy-to-wear sensors with incredible potential to alter the clinical practice of rehabilitation. Using wearable sensors we ha...
Detailed Description
Haemophilia is a rare, inherited disease. Joint and muscle bleeding is the most common symptom, representing 80% of all bleeding episodes.6 Musculoskeletal bleeding triggers a degenerative process cha...
Eligibility Criteria
Inclusion
- Diagnosis of severe or moderate haemophilia (FVIII or FIX ≤ 5%)
- Aged \> 12 years of age
- Inhibitor or non-inhibitor, previous or current
Exclusion
- Diagnosis of mild haemophilia (FVIII or FIX \> 5%)
- Diagnosis of von Willebrand Disease or other bleeding disorder
- Aged ≤ 12 years of age
- Participants requiring a sterile environment
- The use of an oxygen-rich environment at a participant's home
- Participants or another person at the participant's home, with sensitive medical equipment whose functions may be compromised by the introduction of the IMU units, such as a pacemaker or implantable defibrillator
- Bedridden patients
- Patients with severe cognitive or psychiatric disorders as confirmed by a medical diagnosis
Key Trial Info
Start Date :
December 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 12 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06046235
Start Date
December 1 2024
End Date
December 12 2024
Last Update
August 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
EKHUFT
Canterbury, Kent, United Kingdom, CT1 3NG